Cargando…
International Guidelines for the Management and Treatment of Morquio A Syndrome
Morquio A syndrome (mucopolysaccharidosis IVA) is a lysosomal storage disorder associated with skeletal and joint abnormalities and significant non-skeletal manifestations including respiratory disease, spinal cord compression, cardiac disease, impaired vision, hearing loss, and dental problems. The...
Autores principales: | Hendriksz, Christian J, Berger, Kenneth I, Giugliani, Roberto, Harmatz, Paul, Kampmann, Christoph, Mackenzie, William G, Raiman, Julian, Villarreal, Martha Solano, Savarirayan, Ravi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309407/ https://www.ncbi.nlm.nih.gov/pubmed/25346323 http://dx.doi.org/10.1002/ajmg.a.36833 |
Ejemplares similares
-
Impact of long-term elosulfase alfa treatment on respiratory function in patients with Morquio A syndrome
por: Hendriksz, Christian J., et al.
Publicado: (2016) -
Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management
por: Solanki, Guirish A., et al.
Publicado: (2013) -
Orthopedic management of the extremities in patients with Morquio A syndrome
por: White, Klane K., et al.
Publicado: (2014) -
Impact of elosulfase alfa in patients with morquio A syndrome who have limited ambulation: An open‐label, phase 2 study
por: Harmatz, Paul R., et al.
Publicado: (2016) -
Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study
por: Hendriksz, Christian J., et al.
Publicado: (2014)